Edex and Keratitis - a phase IV clinical study of FDA data
We study 3,847 people who take Edex or have Keratitis. No report of Keratitis is found in people who take Edex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Edex?
Edex has active ingredients of alprostadil. eHealthMe is studying from 460 Edex users for its effectiveness, alternative drugs and more.
What is Keratitis?
Keratitis (eye's cornea, the front part of the eye, becomes inflamed) is found to be associated with 1,223 drugs and 763 conditions by eHealthMe.
Do you take Edex and have Keratitis?Check whether Keratitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keratitis and when was it recovered:
Expand to all the drugs that have ingredients of alprostadil:
Alternative drugs to, pros and cons of Edex:
- Edex (460 reports)
Keratitis treatments and more:
- Keratitis (3,387 reports)
COVID vaccines that are related to Keratitis:
- Keratitis in Moderna COVID Vaccine
- Keratitis in Pfizer BioNTech Covid Vaccine
- Keratitis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keratitis:
All the conditions that are associated with Keratitis:
How the study uses the data?
The study uses data from the FDA. It is based on alprostadil (the active ingredients of Edex) and Edex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Novalgin and Parkinson'S Disease Aggravated - 14 seconds ago
- Sedation Aggravated and Hyperkalemia - 33 seconds ago
- Metoprolol Succinate and Second Primary Malignancy - 36 seconds ago
- Digoxin and Gastritis - 37 seconds ago
- Nitroglycerin and Peptic Ulcer Aggravated - 49 seconds ago
- Glucotrol and Arava drug interaction - 52 seconds ago
- Ranitidine and Burning Sensation - 59 seconds ago
- Budesonide and Blood Iron Abnormal - a minute ago
- Chronic Thyroiditis and Bradycardia - a minute ago
- Zometa and Organising Pneumonia - a minute ago